Dr Chris Martin, PhD

Chris has over 20 years of experience in the pharmaceutical and biotech sector. He is an accomplished company founder and Director who has successfully brought technology from the lab to regulatory approval and global markets.

Prior experience:
• Chairman of the Board, Tokamak Energy Ltd (2015-current)
• Co-founder and CEO, ADC Therapeutics (2012 – 2022)
• Non Executive Director, Xenva Ltd (1998 – 2018)
• VP Spirogen, AstraZeneca (2013 – 2015)
• Non Executive Director, Allianz Technology Trust PLC (2004 – 2015)
• Co-founder and CEO, Spirogen Ltd (2000 – 2015)
• Chairman, Crescent Diagnostics (2006 – 2013)
• Co-founder and Chairman, Sciona Inc. (2000 – 2009)

Education:
• MBA from IMD business School
• PhD in Engineering Science from the University of Oxford
• Bachelor’s degree in Chemical Engineering from Aston University